Form 4: Thermo Fisher Scientific Director Jennifer M. Johnson Reports Stock Transactions
SEC Filing
Jennifer M. Johnson, a director at Thermo Fisher Scientific, reported the acquisition and disposal of common stock on May 21, 2025.
Summary
- On May 21, 2025, Jennifer M. Johnson, a director of Thermo Fisher Scientific, reported acquiring 565 shares of common stock.
- On the same day, Johnson disposed of 904 shares of common stock.
- The transactions were reported on a Form 4 filing with the SEC.
- Johnson is also the President and CEO of Franklin Resources, Inc., and disclaims beneficial ownership of Thermo Fisher Scientific securities held by Franklin Templeton subsidiaries.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, helping investors understand their trading activity.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of stock acquisition and disposal. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Thermo Fisher Scientific, Jennifer M. Johnson, Stock Transaction, Director, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.